Praxis Precision Medicines, Inc.
PRAXNasdaqCIK 1689548HealthcareFiscal year ends Dec 31
Reports and events: 127 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0608:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001689548-26-000083 |
| 2026-08-0608:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689548-26-000082 |
| 2026-07-0717:05 ET | 8-K | 8.01 Other events | 0001689548-26-000072 |
| 2026-07-0216:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-26-080356 |
| 2026-06-2916:40 ET | 8-K | 8.01 Other events | 0001689548-26-000069 |
| 2026-06-2216:43 ET | 8-K | 8.01 Other events | 0001689548-26-000066 |
| 2026-06-1216:46 ET | 8-K | 5.07 Shareholder vote results | 0001689548-26-000056 |
| 2026-06-0116:28 ET | 8-K | 8.01 Other events | 0001689548-26-000053 |
| 2026-05-0716:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689548-26-000049 |
| 2026-05-0709:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001689548-26-000047 |
| 2026-04-3016:16 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001689548-26-000039 |
| 2026-04-1417:11 ET | 8-K | 8.01 Other events | 0001689548-26-000033 |
| 2026-04-0616:23 ET | 8-K | 8.01 Other events | 0001689548-26-000031 |
| 2026-02-1908:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001689548-26-000029 |
| 2026-02-1908:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689548-26-000028 |
| 2026-02-1016:52 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001689548-26-000016 |
| 2026-01-0816:49 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001689548-26-000005 |
| 2026-01-0717:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-001825 |
| 2026-01-0616:24 ET | 8-K | 2.02 Results of operations | 0001689548-26-000002 |
| 2025-12-2908:04 ET | 8-K | 8.01 Other events | 0001689548-25-000118 |
| 2025-12-1116:23 ET | 8-K | 8.01 Other events | 0001689548-25-000116 |
| 2025-12-0816:18 ET | 8-K | 8.01 Other events | 0001689548-25-000114 |
| 2025-11-0508:04 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001689548-25-000111 |
| 2025-11-0508:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689548-25-000110 |
| 2025-10-2108:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689548-25-000103 |
| 2025-10-2018:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100488 |
| 2025-10-1607:58 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689548-25-000100 |
| 2025-09-0516:48 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-087865 |
| 2025-08-0408:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689548-25-000094 |
| 2025-08-0408:33 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001689548-25-000092 |
| 2025-07-1708:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001689548-25-000086 |
| 2025-06-2716:47 ET | 8-K | 5.07 Shareholder vote results | 0001689548-25-000075 |
| 2025-05-0217:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689548-25-000062 |
| 2025-05-0208:38 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001689548-25-000058 |
| 2025-05-0208:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689548-25-000056 |
| 2025-04-3016:21 ET | DEF 14A | Proxy statementPeriod 2025-06-26 | 0001689548-25-000050 |
| 2025-02-2808:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001689548-25-000040 |
| 2025-02-2808:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689548-25-000037 |
| 2025-01-2917:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689548-25-000021 |
| 2024-11-0607:59 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001689548-24-000101 |
| 2024-11-0607:57 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689548-24-000098 |
| 2024-10-1508:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-108345 |
| 2024-09-0308:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-096035 |
| 2024-08-1307:22 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001689548-24-000088 |
| 2024-08-1307:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689548-24-000086 |
| 2024-06-0617:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001689548-24-000073 |
| 2024-05-1308:21 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001689548-24-000060 |
| 2024-05-1308:18 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689548-24-000058 |
| 2024-04-2607:46 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001689548-24-000048 |
| 2024-03-2916:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-041158 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.